Schematic illustration shows remarkable SERS activities of self-doped Q-structured TiOx with oxygen vacancies compared to the Q-structured TiO2.

Accurate in vitro molecular-level analysis is an essential step prior to in vivo and clinical application for early diagnosis and cancer treatment. Among the diagnostic techniques, surface-enhanced Raman scattering (SERS) biosensing has shown growing potential due to its noninvasive and real-time characterization of the biomolecules. However, the application of SERS biosensing is mostly limited to the plasmonic noble metals, in the form of either nanoparticles or tips and substrates (fixed probe), on which surface plasmon resonance (SPR) is the prominent enhancement principle. The semiconductor quantum particles have been explored in several optoelectronics applications, but have never been reported to be exploited as a means of surface-enhanced Raman scattering (SERS) for molecular-level and intracellular sensing. Here, we report on the new generation of noble-metal-free SERS probe; Si@SiO2 quantum probe (Si@SiO2 Q-probe) whose affinity to functional groups not only imitates a self-driven labeling attribution that enables charge transfer (CT) as an augmented enhancement principle but also its mobile nature in miniaturized scale facilitates endocytosis for in situ live cell biosensing. Moreover, a significant enhancement factor of 106 of rhodamine 6G (R6G) and 107 of glutathione (GSH) at ∼5 × 10–12 pM concentration has been achieved that is comparable to inherently plasmonic noble metals. Our results showed a capability of the Si@SiO2 Q-probe to unveil the “biochemical fingerprint” of substantial components of mammalian and cancerous cervical cells, which leads to diagnosis of cervical cancer. These unique attributions of the Si@SiO2 Q-probe can provide better insight into cell mutation and malignancy.

The biocompatibility of silicon-based nanomaterials makes them suitable for biophysical and biomedical applications. However, the application of silicon-based nanomaterials has been mainly restricted to nanoparticles (NPs) as a potential drug carrier and the extracellular matrix (ECM) as a platform for cell adhesion and proliferation. Here, we introduce silica NPs self-assembled into a 3D nanoweb architecture that was shown to inherit the therapeutic and proliferative attributes of both NPs and ECMs. The self-assembled silica nanoweb (SNW) has, therefore, not only shown targeted druglike behavior in HeLa cells without the use of biomarkers but has also shown ECM characteristics. The ECM characteristics of SNWs enhanced the cellular attraction and proliferation by which fibroblasts exhibited tissuelike behavior, and HeLa cells underwent an intensified induction of apoptosis. These properties are tailored by the alteration of the polymorphic heterogeneities of the SNW as a novel nanobiointerface for exceptional apoptosis induction through the enhancement of cellular attraction, which, to the best of our knowledge, has not been previously reported. These attributes enable selective functionality with which cancerous HeLa and mammalian fibroblast cells were affected differently. Moreover, simultaneous control of the packing index and crystallinity of the SNWs, to which the cells had been attracted, possessed the additional advantage of modulating the selective functionality of this nanobiointerface. These polymorphic characteristics were tailored by the alteration of the crystallinity of the synthesized SNW via precision control of the ionization level of the silicon substrate, whose requisite ionization energy was generated by an ultrashort pulsed laser. Our results showed that the therapeutic functionality of the SNW-plated template can be elucidated via the endocytosis of amorphous SNWs. Because of the efficient cellular attraction and remarkable contrast in the cellular response to the SNW-plated template, we expect that these findings will provide new insights and opportunities for designing and engineering novel cell-material interfaces for advanced biomedical applications in cancer research.

To achieve regeneration of long sections of damaged nerves, restoration methods such as direct suturing or autologous grafting can be inefficient. Solutions involving biohybrid implants, where neural stem cells are grown in vitro on an active support before implantation, have attracted attention. Using such an approach, combined with recent advancements in microfabrication technology, the chemical and physical environment of cells can be tailored in order to control their behaviors. Herein, a neural stem cell polycarbonate fiber scaffold, fabricated by 3D printing and thermal drawing, is presented. The combined effect of surface microstructure and chemical functionalization using poly-L-ornithine (PLO) and double-walled carbon nanotubes (DWCNTs) on the biocompatibility of the scaffold, induced differentiation of the neural stem cells (NSCs) and channeling of the neural cells was investigated. Upon treatment of the fiber scaffold with a suspension of DWCNTs in PLO (0.039 g l−1) and without recombinants a high degree of differentiation of NSCs into neuronal cells was confirmed by using nestin, galactocerebroside and doublecortin immunoassays. These findings illuminate the potential use of this biohybrid approach for the realization of future nerve regenerative implants.

No abstract

Yttria-stabilized zirconia (YSZ) thin nanocrystalline coatings at different substrate preheating temperatures were deposited via electron beam-physical vapour deposition (EB-PVD). Nanocrystalline ZrO 2 -Y 2 O 3 was deposited on the bond coat in order to compensate for the coefficient of thermal expansion (CTE), which can be functionalized as a thermal barrier coating (TBC). The aim of this study was to evaluate mechanical properties with respect to adhesion of zirconia nanocrystalline's top ceramic layer to the interfacial bond coat by utilizing micro and nano indentation tests. In the present paper, the structural studies were carried out using X-ray diffraction (XRD) analysis of coating content (8 mol% of Y 2 O 3 ). The tetragonal phase of stabilized zirconia was observed. Field emission scanning electron microscopy (FESEM) and atomic force microscopy (AFM) were employed to characterize the coatings' morphology and microstructure. The mechanical behavior of ZrO 2 -Y 2 O 3 thin films under point loading conditions was studied by nanoindentation using a Berkovich indenter with 130 nm tip radius. Therefore, adhesion of top coat to the interfacial underlying metallic bond coat known as MCrAlY (M = Ni, Co) was estimated according to the highest peak load tests; for a 120 mN peak load, the film manifested tolerable adhesion properties. Moreover, nanoindentation of ZrO 2 -Y 2 O 3 nanostructure deposited at 1050 ℃ substrate preheating temperature produced the highest hardness value of about 21.7 GPa. Vickers micro hardness was utilized with the aid of the Tabor equation in order to achieve deeper insight into the correlation between adhesion and deposition process parameters.

Herein, a label‐free multiplex photoluminescent silicon nanoprobe (PLSN‐probe) is introduced as a potential substitute for quantum dots (QDs) in bioimaging. An inherently non‐photoluminescent silicon substrate is altered to create the PLSN‐probe, to overcome the major drawbacks of presently available QDs. Additionally, crystallinity alterations of the multiplane crystalline PLSN‐probes lead to broad absorption and multiplex fluorescence emissions, which are attributed to the simultaneous existence of multiple crystal planes. The PLSN‐probe not only demonstrates unique optical properties that can be exploited for bioimaging but also exhibits cell‐selective uptake that allows the differentiation and diagnosis of HeLa and fibroblast cells. Moreover, multiplex emissions of the PLSN‐probe illuminate different organelles such as the nucleus, nucleolemma, and cytoskeleton, depending on size‐based preferential uptake by the cell organs. This in vitro study reveals that cancerous HeLa cells have a higher propensity for taking up the PLSN‐probe compared to fibroblast cells, allowing the diagnosis of cancerous HeLa cells. Additionally, the fluorescence intensity per unit area of the cell is found to be a reliable means for distinguishing between dead and healthy cells. It is anticipated that the multifunctionality of the PLSN‐probes will lead to better insight into the use of such probes for bioimaging and diagnosis applications.

Biomedical waste management is getting significant consideration among treatment technologies, since insufficient management can cause danger to medicinal service specialists, patients, and their environmental conditions. The improvement of waste administration protocols, plans, and policies are surveyed, despite setting up training programs on legitimate waste administration for all healthcare service staff. Most biomedical waste substances do not degrade in the environment, and may also not be thoroughly removed through treatment processes. Therefore, the long-lasting persistence of biomedical waste can effectively have adverse impact on wildlife and human beings, as well. Hence, photocatalysis is gaining increasing attention for eradication of pollutants and for improving the safety and clearness of the environment due to its great potential as a green and eco-friendly process. In this regard, nanostructured photocatalysts, in contrast to their regular counterparts, exhibit significant attributes such as non-toxicity, low cost and higher absorption efficiency in a wider range of the solar spectrum, making them the best candidate to employ for photodegradation. Due to these unique properties of nanophotocatalysts for biomedical waste management, we aim to critically evaluate various aspects of these materials in the present review and highlight their importance in healthcare service settings.